


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
AQST
Aquestive Therapeutics
$4.17

Login to see Aquestive Therapeutics (AQST) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow
Risk Analysis

Downgraded on weak valued
AQST Price Performance
$4.08 (+2.21%)
$4.14 (+0.72%)
$5.99 (-30.38%)
$3.57 (+16.81%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Loss widens YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
AQST Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AQST Street Sentiment is bullish and have negative views on the near-term outlook
AQST has Medium risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Jan 07, 2026
Upgrade
Buy
Zacks
What is AQST current stock price?
What is AQST current Stock IQ?
What is AQST RSI signal right now?
What is AQST analyst price target and upside potential?
What do analysts say about AQST stock?
What is AQST momentum trend right now?
What are AQST stock strengths?
What is AQST Risk Level?
Should I buy AQST stock right now?
Is AQST a Strong Buy right now?
What is AQST market cap and volume?
What factors influence AQST's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
AQST
Aquestive Therapeutics
Current Price
$4.17

AQST Price Performance
$4.08 (+2.21%)
$4.14 (+0.72%)
$5.99 (-30.38%)
$3.57 (+16.81%)
AQST Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Loss widens YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
AQST Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AQST Street Sentiment is bullish and have negative views on the near-term outlook
AQST has Medium risk level

Overall Wall Street Rating
AQST Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
Risk Analysis

Downgraded on weak valued
AQST Trading Signals
AQST crossed below its 50-day MA ($4.16) at $4.09. Potential bearish reversal.
AQST has closed down for 3 consecutive days
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AQST Stock trends
AQST Stock performance
AQST Stock analysis
AQST investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.